QuickView for ADORA3;jsessionid=AC78C833454AB766596018BCAAE80477;jsessionid=068CD91AF491E16A39B986A0319B9541;jsessionid=53023F4D955117E509C23A54E28921E9;jsessionid=5FE96D433157CF8270CDC20D29FDFBE6;jsessionid=DA3026547DA51EEA40653B0871A226A8 (gene)

1. Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter i…
2. Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage.
3. Pharmacological characterisation of novel adenosine A3 receptor antagonists.
4. Optical control of adenosine A3 receptor function in psoriasis.
5. Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors.

There were no clinical trials for ADORA3;jsessionid=AC78C833454AB766596018BCAAE80477;jsessionid=068CD91AF491E16A39B986A0319B9541;jsessionid=53023F4D955117E509C23A54E28921E9;jsessionid=5FE96D433157CF8270CDC20D29FDFBE6;jsessionid=DA3026547DA51EEA40653B0871A226A8